ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease

ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease
复制标题

DOI:
10.1172/jci200419574
复制
发表时间:
2004-02-01
影响因子:
15.9
通讯作者:
Chen, YT
Chen, YT
中科院分区:
医学1区
文献类型:
--
作者:
Wu, JY;Kao, HJ;Chen, YT

文献摘要

被引文献

相似文献

应用串联质谱法检测了N-乙基-N-亚硝基脲(ENU)处理小鼠的氨基酸和脂肪酸代谢途径的紊乱。我们发现小鼠血液支链氨基酸(BCAAs)显著升高,酮酸尿症,临床特征类似于人类枫糖浆尿病(MSUD),一种严重的遗传代谢紊乱引起的缺乏支链α-酮酸脱氢酶(BCKD)复合物。然而,BCKD基因和酶活性正常。支链氨基转移酶基因(Bcat)的测序结果显示,在胞质亚型(Bcat-1)没有突变,但在线粒体亚型(Bcat-2)中发现了一个纯合剪接位点突变。该突变导致外显子2缺失,BCAT-2 mRNA显著降低,BCAT-2蛋白及其酶活性缺乏。受影响的小鼠对BCAA限制饮食有反应,临床症状改善,氨基酸模式正常化。我们的结论是,BCAT-2缺乏症的小鼠可能会导致一种疾病,模仿人类MSUD。这些小鼠为研究支链氨基酸代谢及其毒性提供了重要的动物模型。代谢组学引导的筛选,加上ENU诱变,是一个强大的方法,在发现新的酶的缺陷和识别遗传代谢紊乱的重要途径。
Tandem mass spectrometry was applied to detect derangements in the pathways of amino acid and fatty acid metabolism in N-ethyl-N-nitrosourea-treated (ENU-treated) mice. We identified mice with marked elevation of blood branched-chain amino acids (BCAAs), ketoaciduria, and clinical features resembling human maple syrup urine disease (MSUD), a severe genetic metabolic disorder caused by the deficiency of branched-chain a-keto acid dehydrogenase (BCKD) complex. However, the BCKD genes and enzyme activity were normal. Sequencing of branched-chain aminotransferase genes (Bcat) showed no mutation in the cytoplasmic isoform (Bcat-1) but revealed a homozygous splice site mutation in the mitochondrial isoform (Bcat-2). The mutation caused a deletion of exon 2, a marked decrease in Bcat-2 mRNA, and a deficiency in both BCAT-2 protein and its enzyme activity. Affected mice responded to a BCAA-restricted diet with amelioration of the clinical symptoms and normalization of the amino acid pattern. We conclude that BCAT-2 deficiency in the mouse can cause a disease that mimics human MSUD. These mice provide an important animal model for study of BCAA metabolism and its toxicity. Metabolomics-guided screening, coupled with ENU mutagenesis, is a powerful approach in uncovering novel enzyme deficiencies and recognizing important pathways of genetic metabolic disorders.